Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis-Reference-Cited by-同舟云学术

Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis

Published:2017-06-18 Issue:6 Volume:8 Page:915-925
ISSN:2190-5991
Container-title:Journal of Cachexia, Sarcopenia and Muscle
language:en
Short-container-title:Journal of Cachexia, Sarcopenia and Muscle

Author:

Nishikawa Hiroki¹,Enomoto Hirayuki¹,Ishii Akio¹,Iwata Yoshinori¹,Miyamoto Yuho¹,Ishii Noriko¹,Yuri Yukihisa¹,Hasegawa Kunihiro¹,Nakano Chikage¹,Nishimura Takashi¹,Yoh Kazunori¹,Aizawa Nobuhiro¹,Sakai Yoshiyuki¹,Ikeda Naoto¹,Takashima Tomoyuki¹,Takata Ryo¹,Iijima Hiroko¹,Nishiguchi Shuhei¹

Affiliation:

1. Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine; Hyogo College of Medicine; Nishinomiya Hyogo Japan

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcsm.12212/fullpdf

Reference46 articles.

1. Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses;Periyalwar;Clin Liver Dis,2012

2. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS);Cruz-Jentoft;Age Ageing,2014

3. Review article: sarcopenia in cirrhosis - aetiology, implications and potential therapeutic interventions;Sinclair;Aliment Pharmacol Ther,2016